|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Inari Medical, Inc. (NARI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
58,266,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Inari Medical is a commercial-stage medical device company. Co. is engaged in the development, manufacturing, marketing and selling of devices for the interventional treatment of venous diseases. Co. offers catheter-based technologies for the treatment of venous thromboembolism. Co. also develops solutions that enables the safe removal of clot volumes from big vessels without the use of thrombolytic drugs. Co.'s development products include ClotTriever (a mechanical thrombectomy system) and FlowTriever (a bore catheter-based aspiration and mechanical thrombectomy system).
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
56,100 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,998,063 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
200,000 |
635,000 |
1,195,725 |
| Total Sell Value |
$0 |
$12,093,175 |
$34,409,262 |
$65,207,609 |
| Total People Sold |
0 |
1 |
4 |
5 |
| Total Sell Transactions |
0 |
1 |
22 |
51 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mead Dana G Jr |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,148) |
0 |
|
- |
|
| Hykes Andrew |
President and CEO |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(717,637) |
0 |
|
- |
|
| Hykes Andrew |
President and CEO |
• • – |
2025-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
20,393 |
717,637 |
|
- |
|
| Hykes Andrew |
President and CEO |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,650) |
0 |
|
- |
|
| Strange Kevin T |
Chief Financial Officer |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(67,502) |
0 |
|
- |
|
| Milder Donald B |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,831,714) |
0 |
|
- |
|
| Milder Donald B |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(259,126) |
0 |
|
- |
|
| Chambers Rebecca |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,684) |
0 |
|
- |
|
| Root Jonathan D |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(335) |
0 |
|
- |
|
| Root Jonathan D |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(541,149) |
0 |
|
- |
|
| Hoffman William |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(238,987) |
0 |
|
- |
|
| Lucchese Cynthia L |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(38,429) |
0 |
|
- |
|
| Silva Karen |
Principal Accounting Officer |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,719) |
0 |
|
- |
|
| Szyman Catherine M |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,429) |
0 |
|
- |
|
| Tu Thomas |
Chief Medical Officer |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(478,767) |
0 |
|
- |
|
| Tu Thomas |
Chief Medical Officer |
• • – |
2025-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
7,406 |
478,767 |
|
- |
|
| Warner Robert Keith |
Director |
• • – |
2025-02-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,149) |
0 |
|
- |
|
| Tu Thomas |
Chief Medical Officer |
• • – |
2025-02-10 |
4 |
OE |
$0.46 |
$118,124 |
D/D |
148,004 |
471,361 |
|
- |
|
| Hykes Andrew |
President and CEO |
• • – |
2025-02-10 |
4 |
OE |
$0.43 |
$184,569 |
D/D |
194,538 |
697,244 |
|
- |
|
| Tu Thomas |
Chief Medical Officer |
• • – |
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
21,102 |
323,357 |
|
- |
|
| Hykes Andrew |
President and CEO |
• • – |
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
67,282 |
502,706 |
|
- |
|
| Strange Kevin T |
Chief Financial Officer |
• • – |
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
21,102 |
67,502 |
|
- |
|
| Silva Karen |
Principal Accounting Officer |
• • – |
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,504 |
14,719 |
|
- |
|
| Hoffman William |
Director |
• • – |
2025-01-06 |
4 |
AS |
$60.13 |
$12,093,175 |
D/D |
(200,000) |
238,987 |
|
- |
|
| Hykes Andrew |
President and CEO |
• • – |
2025-01-01 |
4 |
D |
$51.05 |
$225,079 |
D/D |
(4,409) |
434,901 |
|
- |
|
518 Records found
|
|
Page 1 of 21 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
